Summary
Laboratorios Del Dr Esteve SA (Esteve) is a pharmaceutical company that researches, develops and markets new drugs and formulations. The company's product portfolio encompasses prescription drugs, over-the-counter (OTC) products and generic drugs. It offers drugs in the therapeutic areas of central nervous system, analgesia, respiratory, onco-haematology and primary care, among others. Esteve markets its products to pharmaceutical companies, healthcare facilities, and other customers through licensing agreements and distributors. The company, together with its subsidiaries and representative offices, operates in the US, Mexico, Germany, Sweden, China, Italy, Portugal, Spain and Turkey. It has production facilities in Mexico and China. Esteve is headquartered in Barcelona, Spain.
Laboratorios Del Dr Esteve SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 12
Partnerships 13
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 13
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 14
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 15
Esteve Enters into Agreement with AstraZeneca 15
Eisai Enters into Agreement with Esteve 16
Enzymatica Enters into Distribution Agreement with Esteve 17
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 18
Breckenridge Pharma Enters into Co-Marketing Agreement with MSN Labs for ANDAs 19
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 19
SEFAC and Esteve Forms partnership 20
Eisai Enters into Co-Marketing Agreement with Esteve for Zonegran 21
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 22
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA 22
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 23
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet 24
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 25
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 26
Breckenridge Pharma Enters Into Co-Marketing Agreement With Oman Pharma Products 26
Licensing Agreements 27
ReGenX Biosciences Enters Into Licensing Agreement With Esteve 27
Asset Transactions 28
Ecuphar Acquires Veterinary Division from Esteve 28
Laboratorios Del Dr Esteve SA - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Product News 34
Feb 25, 2016: ESTEVE Provides Update On EGT-101 For Sanfilippo A Syndrome 34
Feb 25, 2016: ESTEVE Provides Update On EGT-201 For Sanfilippo B Syndrome 35
Feb 25, 2016: ESTEVE Provides Update On EGT-301 For Hunter Syndrome 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Laboratorios Del Dr Esteve SA, Deals By Therapy Area, 2011 to YTD 2017 9
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 12
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 13
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 14
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 15
Esteve Enters into Agreement with AstraZeneca 15
Eisai Enters into Agreement with Esteve 16
Enzymatica Enters into Distribution Agreement with Esteve 17
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 18
Breckenridge Pharma Enters into Co-Marketing Agreement with MSN Labs for ANDAs 19
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 19
SEFAC and Esteve Forms partnership 20
Eisai Enters into Co-Marketing Agreement with Esteve for Zonegran 21
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 22
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA 22
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 23
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet 24
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 25
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 26
Breckenridge Pharma Enters Into Co-Marketing Agreement With Oman Pharma Products 26
ReGenX Biosciences Enters Into Licensing Agreement With Esteve 27
Ecuphar Acquires Veterinary Division from Esteve 28
Laboratorios Del Dr Esteve SA, Key Competitors 30
Laboratorios Del Dr Esteve SA, Key Employees 31
Laboratorios Del Dr Esteve SA, Other Locations 32
Laboratorios Del Dr Esteve SA, Subsidiaries 32List of Figures
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
